We are live on
!
Find out more
KCM
KRS Capital Management Portfolio holdings
AUM
$215M
1-Year Est. Return
69.3%
This Fund
S&P 500
This Quarter
Est. Return
+23.08%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$16.5M
(+15%)
Cap. Flow
-$1.03M
Cap. Flow
% of AUM
-0.83%
Top 10 Holdings %
Top 10 Hldgs %
48.52%
Holding
122
New
8
Increased
43
Reduced
55
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$428K |
| 2 |
Snowflake
SNOW
|
+$327K |
| 3 |
Dell
DELL
|
+$244K |
| 4 |
Amgen
AMGN
|
+$235K |
| 5 |
Zscaler
ZS
|
+$219K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$748K |
| 2 |
NVIDIA
NVDA
|
+$603K |
| 3 |
Blackrock
BLK
|
+$241K |
| 4 |
Airbnb
ABNB
|
+$216K |
| 5 |
Procter & Gamble
PG
|
+$189K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 56.53% |
| 2 | Healthcare | 12.44% |
| 3 | Financials | 6.81% |
| 4 | Consumer Discretionary | 6.22% |
| 5 | Industrials | 5.21% |
Similar funds
VFG
IAM
VEA
RC
NCM
TSS
CMBA
SSA
KRS Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, KRS Capital Management held 122 positions worth $124M, up 15% from $107M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
KRS Capital Management's Q1 2024 filing shows 8 new, 43 increased, 55 reduced and 4 closed positions. Its largest new stake was RTX Corp: 4,739 shares worth $462K. The largest sale was Karuna Therapeutics, Inc. Common Stock, an estimated $748K.
By sector, the portfolio is most concentrated in Technology at 57% of assets, up from 52% a quarter earlier, followed by Healthcare and Financials.
- KRS Capital Management's largest Q1 2024 buy was RTX Corp: 4,739 shares worth $462K.
- KRS Capital Management added most to Snowflake in Q1 2024, an estimated $327K increase.
- KRS Capital Management's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $603K.
- KRS Capital Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $748K.
- KRS Capital Management's ten largest holdings make up 49% of its $124M portfolio in Q1 2024.
- KRS Capital Management opened 8 new positions and closed 4 in Q1 2024.
- KRS Capital Management's portfolio value rose 15% quarter-over-quarter to $124M.
Based on KRS Capital Management's 13F filing for Q1 2024, filed 16 Apr 2024.